selected publications
-
Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.
Cancer discovery.
2017
Academic Article
GET IT
Times cited: 306 -
R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma.
Blood.
2015
Academic Article
GET IT
Times cited: 265 -
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2014
Academic Article
GET IT
Times cited: 86 -
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma.
Neuro-oncology.
2012
Academic Article
GET IT
Times cited: 90 -
Pearls: primary brain tumors.
Seminars in neurology.
2010
Article
GET IT
Times cited: 1 -
A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases.
Journal of neuro-oncology.
2007
Academic Article
GET IT
Times cited: 39 -
Myelosuppression in patients benefiting from imatinib with hydroxyurea for recurrent malignant gliomas.
Journal of neuro-oncology.
2007
Academic Article
GET IT
Times cited: 10 -
Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2006
Academic Article
GET IT
Times cited: 212 -
Brain metastases: epidemiology and pathophysiology.
Journal of neuro-oncology.
2005
Information Resource
GET IT
Times cited: 576 - Diagnosis and treatment of primary central nervous system lymphoma. Current oncology reports. 2005 Information Resource GET IT
-
Primary central nervous system lymphoma.
Current oncology reports.
2004
Information Resource
GET IT
Times cited: 6